Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Psychiatry
Volume 2015, Article ID 457947, 4 pages
http://dx.doi.org/10.1155/2015/457947
Case Report

New-Onset Panic, Depression with Suicidal Thoughts, and Somatic Symptoms in a Patient with a History of Lyme Disease

1Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
2Silver Hill Hospital, New Canaan, CT 06840, USA
3Department of Psychiatry, Yale School of Medicine, New Haven, CT 06511, USA
4Department of Psychiatry, Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, CA 90024, USA

Received 2 January 2015; Accepted 14 March 2015

Academic Editor: Liliana Dell’Osso

Copyright © 2015 Amir Garakani and Andrew G. Mitton. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. C. Steere, “Lyme disease,” The New England Journal of Medicine, vol. 345, no. 2, pp. 115–125, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. B. A. Fallon and J. A. Nields, “Lyme disease: a neuropsychiatric illness,” The American Journal of Psychiatry, vol. 151, no. 11, pp. 1571–1583, 1994. View at Publisher · View at Google Scholar · View at Scopus
  3. B. A. Fallon, J. A. Nields, B. Parsons, M. R. Liebowitz, and D. F. Klein, “Psychiatric manifestations of Lyme borreliosis,” The Journal of Clinical Psychiatry, vol. 54, no. 7, pp. 263–268, 1993. View at Google Scholar · View at Scopus
  4. B. A. Fallon, M. Schwartzberg, R. Bransfield et al., “Late-stage neuropsychiatric lyme borreliosis: differential diagnosis and treatment,” Psychosomatics, vol. 36, no. 3, pp. 295–300, 1995. View at Publisher · View at Google Scholar · View at Scopus
  5. V. T. Sherr, “Panic attacks may reveal previously unsuspected chronic disseminated lyme disease,” Journal of Psychiatric Practice, vol. 6, no. 6, pp. 352–356, 2000. View at Publisher · View at Google Scholar
  6. A. L. Hassett, D. C. Radvanski, S. Buyske, S. V. Savage, and L. H. Sigal, “Psychiatric comorbidity and other psychological factors in patients with ‘chronic Lyme disease’,” American Journal of Medicine, vol. 122, no. 9, pp. 843–850, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. L. Hassett, D. C. Radvanski, S. Buyske et al., “Role of psychiatric comorbidity in chronic Lyme disease,” Arthritis Care and Research, vol. 59, no. 12, pp. 1742–1749, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. B. A. Fallon, E. S. Levin, P. J. Schweitzer, and D. Hardesty, “Inflammation and central nervous system Lyme disease,” Neurobiology of Disease, vol. 37, no. 3, pp. 534–541, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Jacek, B. A. Fallon, A. Chandra, M. K. Crow, G. P. Wormser, and A. Alaedini, “Increased IFNα activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficits,” Journal of Neuroimmunology, vol. 255, no. 1-2, pp. 85–91, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. P. M. Lantos, “Chronic Lyme disease: the controversies and the science,” Expert Review of Anti-Infective Therapy, vol. 9, no. 7, pp. 787–797, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. V. Cairns and J. Godwin, “Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms,” International Journal of Epidemiology, vol. 34, no. 6, pp. 1340–1345, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. B. A. Fallon, E. Petkova, J. G. Keilp, and C. B. Britton, “A reappraisal of the U.S. clinical trials of post-treatment Lyme disease syndrome,” The Open Neurology Journal, vol. 6, pp. 79–87, 2012. View at Publisher · View at Google Scholar
  13. W. Berghoff, “Chronic lyme disease and co-infections: differential diagnosis,” The Open Neurology Journal, vol. 6, no. 1, pp. 158–178, 2012. View at Publisher · View at Google Scholar
  14. L. H. Sigal and A. L. Hassett, “Commentary: ‘What's in a name? That which we call a rose by any other name would smell as sweet.’ Shakespeare W. Romeo and Juliet, II, ii(47-48),” International Journal of Epidemiology, vol. 34, no. 6, pp. 1345–1347, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. H. M. Feder Jr., B. J. B. Johnson, S. O'Connell et al., “A critical appraisal of ‘chronic lyme disease’,” The New England Journal of Medicine, vol. 357, no. 14, pp. 1422–1430, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. P. G. Auwaerter, J. S. Bakken, R. J. Dattwyler et al., “Antiscience and ethical concerns associated with advocacy of Lyme disease,” The Lancet Infectious Diseases, vol. 11, no. 9, pp. 713–719, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. P. G. Auwaerter and M. T. Melia, “Bullying Borrelia: when the culture of science is under attack,” Transactions of the American Clinical and Climatological Association, vol. 123, pp. 79–90, 2012. View at Google Scholar · View at Scopus
  18. D. Whelan, Forbes, Lyme, 2007, ()http://www.forbes.com/forbes/2007/0312/096.html.
  19. FDA Public Health Advisory, Assays for Antibodies to Borrelia burgdorferi; Limitations, Use, and Interpretation for Supporting a Clinical Diagnosis of Lyme Disease, 2013, http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/ucm062429.htm.
  20. A. Marques, M. R. Brown, and T. A. Fleisher, “Natural killer cell counts are not different between patients with post-Lyme disease syndrome and controls,” Clinical and Vaccine Immunology, vol. 16, no. 8, pp. 1249–1250, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Specter, “The lyme wars,” The New Yorker, 2013, http://www.newyorker.com/reporting/2013/07/01/130701fa_fact_specter. View at Google Scholar
  22. G. Csallner, H. Hofmann, and C. Hausteiner-Wiehle, “Patients with ‘organically unexplained symptoms’ presenting to a borreliosis clinic: clinical and psychobehavioral characteristics and quality of life,” Psychosomatics, vol. 54, no. 4, pp. 359–366, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. J. A. Whitson and A. D. Galinsky, “Lacking control increases illusory pattern perception,” Science, vol. 322, no. 5898, pp. 115–117, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. B. R. Cassileth, E. J. Lusk, T. B. Strouse et al., “Psychosocial status in chronic illness—a comparative analysis of six diagnostic groups,” The New England Journal of Medicine, vol. 311, no. 8, pp. 506–511, 1984. View at Publisher · View at Google Scholar · View at Scopus
  25. S. S. Khalsa, L. Shahabi, O. A. Ajijola, A. Bystritsky, B. D. Naliboff, and K. Shivkumar, “Synergistic application of cardiac sympathetic decentralization and comprehensive psychiatric treatment in the management of anxiety and electrical storm,” Frontiers in Integrative Neuroscience, vol. 7, article 98, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Weissenbacher, J. Ring, and H. Hofmann, “Gabapentin for the symptomatic treatment of chronic neuropathic pain in patients with late-stage lyme borreliosis: a pilot study,” Dermatology, vol. 211, no. 2, pp. 123–127, 2005. View at Publisher · View at Google Scholar · View at Scopus